gener
vaccin
materi
consist
specif
antigen
ag
adjuv
capabl
potenti
immunogen
ag
achiev
effici
agspecif
adapt
immun
vaccin
made
live
attenu
andor
kill
whole
pathogen
usual
contain
endogen
adjuv
bacteri
cell
wall
compon
genom
nucleic
acid
variou
pathogenderiv
materi
act
pathogenassoci
molecular
pattern
suffici
induc
agspecif
adapt
immun
potenti
immunogen
activ
innat
immun
howev
subunit
vaccin
util
recombin
andor
purifi
ag
usual
lack
endogen
innat
immun
stimul
consequ
addit
exogen
materi
adjuv
activ
requir
mimic
natur
infect
draw
effect
pathogen
agspecif
adapt
immun
innat
immun
respons
includ
product
interferon
ifn
complement
antimicrobi
peptid
amp
crucial
control
infecti
diseas
induc
adapt
immun
amp
propos
multifunct
peptid
particip
elimin
pathogen
microorgan
includ
bacteria
fungi
virus
particular
defensin
one
major
amp
famili
mammal
contribut
antimicrobi
innat
immun
respons
disrupt
cell
membran
pathogen
six
express
human
human
hbd
unlik
produc
wide
varieti
epitheli
tissu
includ
skin
mucosa
cell
includ
phagocyt
cell
mucos
epitheli
cell
express
defens
gene
tightli
regul
cytokin
part
host
defens
suppress
variou
virul
factor
pathogen
import
note
amp
recent
report
modul
adapt
immun
trigger
recruit
activ
immun
cell
via
variou
pathway
link
innat
immun
exampl
hbd
chemotact
immatur
dendrit
cell
dc
memori
cell
site
pathogen
invas
interact
promot
adapt
immun
respons
recruit
immun
cell
howev
antivir
immunemodulatori
function
viral
infect
clearli
elucid
crucial
innat
immun
cell
neutrophil
macrophag
investig
use
amp
adjuv
stimul
induct
antivir
innat
immun
also
agspecif
adapt
immun
respons
use
hbd
receptorbind
domain
rbd
middl
east
respiratori
syndromecoronaviru
merscov
spike
protein
rbd
model
ag
assess
immunemodulatori
activ
hbd
macrophagelik
cell
determin
activ
particip
hbd
innat
immun
viru
infect
addit
confirm
adjuv
activ
hbd
vivo
determin
level
agspecif
immun
respons
induct
administr
hbd
rbd
six
eightweekold
femal
mice
purchas
koatech
laboratori
anim
center
pyeongtaek
korea
hous
specif
pathogenfre
condit
water
food
provid
ad
libitum
anim
experi
approv
institut
anim
care
use
committe
chonbuk
nation
univers
approv
cbnu
follow
guidelin
suggest
committe
vero
cell
obtain
american
type
cultur
collect
manassa
va
usa
cell
kclb
obtain
korean
cell
line
bank
seoul
korea
merscov
obtain
korean
center
diseas
control
prevent
kcdc
experi
use
merscov
perform
accord
world
health
organ
recommend
biosafeti
level
condit
biosafeti
level
facil
korea
zoonosi
research
institut
chonbuk
nation
univers
unless
otherwis
specifi
chemic
laboratori
ware
use
studi
obtain
sigma
chemic
co
st
loui
mo
usa
spl
life
scienc
pocheon
korea
respect
gene
recombin
express
purif
recombin
merscov
rbd
without
hbd
c
terminu
rbd
residu
domain
perform
describ
previous
minor
modif
briefli
gene
encod
rbd
synthes
codon
optim
base
merscov
protein
sequenc
genbank
genscript
piscataway
nj
usa
rbd
gene
hbd
gene
terminu
amplifi
polymeras
chain
reaction
pcr
use
forward
primer
ctc
aag
tat
tat
tct
atc
att
underlin
letter
repres
saci
restrict
site
hbd
gene
togeth
revers
primer
aga
tca
tgg
ctt
ttt
gca
gca
ttt
tgt
tcc
agg
gag
acc
aca
ggt
gcc
aat
ttg
ttt
ata
cct
tct
agg
gca
aaa
gac
tgg
atg
aca
tat
ggc
tcc
act
ctt
aag
gca
ggt
aac
agg
atc
gcc
tat
acc
ctc
tac
gaa
caa
aga
underlin
italic
letter
repres
xbai
restrict
site
hbd
sequenc
respect
amplifi
gene
clone
pcoldii
escherichia
coli
express
vector
takara
bio
shiga
japan
recombin
protein
purifi
ninta
superflow
qiagen
valencia
ca
usa
protein
ntermin
tag
accord
manufactur
instruct
residu
endotoxin
contamin
filter
use
sartobind
membran
chromatographi
system
sartoriu
goettingen
germani
final
endotoxin
content
recombin
protein
eu
per
protein
determin
use
lal
chromogen
endotoxin
quantif
kit
thermofisch
scientif
rockford
il
usa
cell
cultur
rpmi
medium
welgen
gyeongsan
korea
supplement
fetal
bovin
serum
fb
gibco
grand
island
ny
usa
humidifi
incub
cell
treat
cell
day
differenti
monocytederiv
macrophag
cell
cell
replenish
fresh
media
maintain
day
treat
recombin
protein
per
cell
cell
harvest
h
h
recombin
protein
treatment
subject
quantit
realtim
pcr
qrtpcr
assess
express
level
target
gene
time
cell
cultur
supernat
collect
subject
express
profil
cytokin
chemokin
protein
relat
innat
immun
use
legendplex
human
proinflammatori
chemokin
type
iiiiii
interferon
panel
biolegend
san
diego
ca
usa
accord
manufactur
protocol
perform
rna
extract
use
reagent
thermofish
scientif
waltham
usa
accord
manufactur
instruct
convert
prepar
rna
cdna
use
mmlv
revers
transcript
kit
promega
fitchburg
wi
usa
quantifi
gene
express
via
qrtpcr
use
quantitect
sybr
green
pcr
kit
qiagen
hilden
germani
abi
system
appli
biosystem
foster
citi
ca
usa
use
ng
firststrand
cdna
follow
condit
min
follow
amplif
cycl
normal
express
level
gene
hactb
via
rel
quantif
method
use
fast
softwar
version
appli
biosystem
genespecif
primer
set
use
amplifi
gene
list
tabl
mice
immun
subcutan
base
tail
intramuscularli
hind
leg
recombin
protein
dissolv
phosphatebuff
salin
pb
emulsifi
equal
volum
freund
complet
adjuv
boost
immunogen
emulsifi
freund
incomplet
adjuv
day
first
immun
control
mice
immun
inoculum
prepar
ident
pb
sera
collect
day
boost
immun
assess
merscov
rbdspecif
antibodi
ab
respons
level
merscov
rbdspecif
ab
mous
sera
determin
elisa
briefli
elisa
plate
thermofish
scientif
precoat
rbd
protein
overnight
block
nonfat
dri
milk
h
addit
serial
dilut
sera
well
plate
incub
h
follow
four
wash
pb
contain
tween
bound
ab
incub
alkalin
phosphateconjug
antimous
igg
h
reaction
visual
addit
pnitrophenyl
phosphat
substrat
measur
color
develop
use
read
absorb
nm
elisa
plate
reader
spectrostar
nano
bmg
labtech
ortenberg
germani
vero
cell
use
propag
merscov
grown
dulbecco
modifi
eagl
medium
dmem
welgen
supplement
fb
gibco
humidifi
incub
merscov
pass
six
time
vero
cell
use
assess
neutral
potenti
recombin
protein
briefli
sera
obtain
mice
immun
recombin
protein
dilut
incub
h
room
temperatur
rbd
protein
transfer
cell
grown
confoc
dish
immunofluoresc
assay
cell
monolay
fix
paraformaldehyd
treat
premixtur
sera
rbd
protein
pentahi
ab
coupl
alexa
qiagen
use
secondari
ab
cell
cover
slowfad
gold
antifad
reagent
invitrogen
grand
island
ny
usa
slide
observ
confoc
laser
scan
microscop
clsm
lsm
carl
zeiss
thornwood
ny
usa
addit
receptor
bind
inhibit
assay
perform
merscovsuscept
vero
cell
describ
median
fluoresc
intens
measur
use
cytoflex
flow
cytomet
beckmancoult
indianapoli
usa
assess
neutral
capac
individu
serum
sampl
determin
viral
load
merscovinfect
cell
quantifi
level
upstream
e
upe
gene
express
use
qrtpcr
briefli
dilut
mous
immun
sera
incub
h
room
temperatur
plaqueform
unit
pfu
merscov
transfer
vero
cell
cellswel
grown
tissu
cultur
plate
h
incub
extract
total
rna
perform
qrtpcr
describ
previous
use
primer
set
list
tabl
measur
level
merscov
upe
gene
express
statist
analys
perform
use
prism
graphpad
san
diego
ca
usa
data
present
mean
standard
deviat
sd
statist
signific
numer
data
analyz
use
twoway
analysi
varianc
anova
p
consid
statist
signific
macrophag
one
crucial
immun
cell
involv
antivir
innat
immun
assess
influenc
hbd
antivir
innat
immun
respons
induct
determin
express
level
mrna
encod
cytokineschemokin
associ
antivir
innat
immun
qrtpcr
macrophagelik
cell
treat
recombin
rbd
without
hbd
conjug
h
h
fig
specif
analyz
cytokin
gene
associ
classic
antivir
immun
mxa
acquir
immun
induct
well
chemokin
rant
cytokin
chemokin
select
base
known
function
vitro
vivo
use
variou
virus
associ
respiratori
diseas
includ
sever
acut
respiratori
syndromecoronaviru
sarscov
merscov
hbd
rbd
treatment
cell
significantli
p
p
promot
earli
induct
h
h
type
ifn
mxa
type
ifninduc
molecul
broad
antivir
activ
type
ii
ifn
transcript
compar
treatment
rbd
without
hbd
conjug
fig
transcript
level
mxa
substanti
elev
h
hbd
ag
treatment
remain
strongli
induc
h
ag
treatment
fig
addit
level
cytokin
chemokin
gene
test
significantli
higher
hbd
agtreat
cell
control
pbstreat
cell
fig
import
note
level
rant
significantli
higher
hbd
agtreat
cell
cell
treat
rbd
alon
fig
g
h
k
addit
transcript
level
analyz
gene
increas
treatment
time
increas
h
h
specul
hbd
rbd
treatment
enhanc
express
wellknown
innat
responseinduc
cytokin
chemokin
promot
recruit
leukocyt
capabl
control
primari
adapt
immun
site
pathogen
infect
confirm
enhanc
express
gene
relat
innat
immun
hbd
rbd
treatment
determin
express
level
cytokin
chemokin
protein
involv
innat
immun
fig
first
examin
protein
level
type
iiiiii
interferon
counteract
viru
infect
found
qrtpcr
result
hbd
rbd
treatment
cell
significantli
p
promot
express
compar
cell
treat
rbd
without
hbd
fig
protein
level
primari
chemokin
lead
initi
innat
immun
respons
changeov
adapt
immun
respons
also
determin
cell
treat
rbd
without
conjug
fig
chemokin
express
profil
also
consist
qrtpcr
result
significantli
enhanc
chemokin
protein
express
observ
hbd
rbdtreat
cell
compar
cell
treat
rbd
alon
addit
mxa
inhibitor
rna
viru
replic
analyz
express
gene
involv
viru
gene
express
fig
gene
includ
pkr
doublestrand
rnadepend
protein
kinas
rnase
l
endogen
ribonucleas
pkr
gene
express
significantli
higher
hbd
agtreat
cell
control
pbstreat
cell
howev
differ
cell
treat
either
hbd
nonconjug
agtreat
cell
statist
signific
although
hbd
ag
treatment
upregul
express
pkr
cell
h
treatment
fig
interest
transcript
level
rnasel
significantli
higher
hbd
rbdtreat
cell
h
treatment
cell
treat
rbd
without
hbd
conjug
signific
differ
maintain
h
treatment
fig
c
import
hbd
ag
treatment
provok
rapid
strong
induct
express
cell
compar
treatment
rbd
alon
fig
result
indic
gene
express
antivir
innat
adapt
immun
responseassoci
molecul
effici
activ
cell
respond
hbd
next
analyz
whether
hbd
capabl
promot
induct
adapt
immun
respons
specif
hbd
rbd
fig
determin
level
rbdspecif
ab
sera
induc
day
boost
immun
found
inject
hbd
rbd
induc
significantli
p
higher
titer
rbdspecif
ab
compar
induc
inject
rbd
without
hbd
conjug
fig
rbdspecif
igg
level
significantli
p
higher
ngml
sera
obtain
mice
inject
hbd
rbd
compar
ngml
mice
inject
control
rbd
without
hbd
conjug
fig
result
suggest
hbd
conjug
capabl
mediat
conjug
agspecif
adapt
immun
respons
induct
hbd
exert
adjuv
activ
specif
immun
induct
hbd
ag
high
level
viral
agspecif
ab
well
virusneutr
ab
immun
sera
critic
correl
effect
viru
protect
viral
agspecif
immun
induct
consequ
measur
neutral
activ
ab
induc
immun
hbd
ag
fig
first
assess
whether
sera
obtain
mice
immun
hbd
rbd
could
inhibit
bind
cognat
ag
specif
receptorexpress
cell
monitor
bind
effici
rbd
merscov
receptor
cell
found
sera
mice
immun
hbd
rbd
effici
inhibit
bind
ag
compar
obtain
mice
immun
either
pb
rbd
without
hbd
conjug
fig
next
perform
receptor
bind
inhibit
assay
merscovsuscept
vero
cell
line
use
sera
obtain
mice
immun
pb
rbd
hbd
rbd
fig
shown
flow
cytometri
data
rbd
protein
bound
effici
surfac
vero
cell
red
line
upper
left
panel
importantli
incub
sera
hbd
rbd
mice
show
almost
complet
inhibit
rbd
bind
cell
surfac
blue
line
lower
right
panel
compar
mice
immun
rbd
alon
ca
inhibit
skyblu
line
lower
left
panel
contrast
sera
pbsimmun
mice
exhibit
signific
inhibit
rbd
bind
target
cell
surfac
green
line
upper
right
panel
final
examin
whether
merscov
load
host
cell
effici
inhibit
immun
sera
mice
measur
transcript
level
upe
gene
merscov
vero
cell
infect
viru
preincub
mice
sera
via
qrtpcr
found
sera
mice
immun
hbd
rbd
display
significantli
higher
inhibitori
activ
merscov
upe
gene
express
compar
mice
immun
either
control
pb
rbd
without
hbd
conjug
p
p
respect
fig
result
indic
hbd
rbd
superior
unconjug
rbd
induc
neutral
ab
merscov
infect
capabl
promot
protect
immun
respons
viru
infect
conclud
hbd
could
use
adjuv
induc
effici
innat
protect
adapt
immun
viral
ag
human
defensin
effector
peptid
produc
variou
cell
type
broad
antibacteri
antivir
antifung
activ
defensin
small
cysteinerich
cation
amphipath
protein
antivir
antibacteri
activ
origin
attribut
lipid
perturb
activ
disrupt
viral
glycoprotein
function
membran
lipid
perturb
lead
inhibit
receptor
bind
fusion
envelop
viru
host
cell
howev
observ
sever
class
nonenvelop
virus
also
sensit
defensin
led
discoveri
addit
antivir
mechan
defensin
although
addit
mechan
includ
receptor
downregul
disrupt
earli
event
viral
infect
univers
mechan
neutral
nonenvelop
virus
remain
elus
addit
antibacteri
antivir
activ
defensin
one
strongest
central
peripher
defend
pathogen
infect
particularli
link
innat
adapt
immun
pathogen
infect
leukocyt
dc
cell
addit
potent
adjuv
need
enhanc
immunogen
protect
efficaci
subunit
vaccin
pathogen
thu
investig
adjuv
effect
defensin
antivir
innat
pathogen
agspecif
adapt
immun
respons
use
hbd
analyz
potenti
use
develop
subunit
vaccin
selfadjuv
activ
hbd
ag
treatment
macrophagelik
cell
enhanc
transcript
level
antivir
molecul
includ
mxa
pkr
rnasel
primari
immun
responseregul
cytokin
chemokin
although
induct
level
vari
fig
ifn
divid
type
type
ii
ifn
like
type
ii
ifn
type
ifn
induc
viral
infect
confer
antivir
activ
host
ifn
exert
antivir
activ
enhanc
express
numer
gene
antivir
activ
includ
mxa
cytoplasm
gtpase
inhibit
replic
sever
rna
virus
doublestrand
rnadepend
protein
kinas
pkr
endogen
ribonucleas
rnasel
also
antivir
effector
protein
contrast
mxa
activ
pkr
requir
bind
doublestrand
rna
activ
pkr
lead
translat
arrest
via
phosphoryl
essenti
translat
initi
factor
turn
activ
endogen
ribonucleas
rnase
l
subsequ
cleav
singlestrand
rna
includ
mrna
viral
host
cell
origin
found
express
activ
hbd
ag
treatment
cell
fig
recent
identifi
bacteri
receptor
contribut
crosstalk
innat
adapt
immun
system
digest
tract
also
function
cytoplasm
viral
pattern
recognit
receptor
trigger
activ
ifnregulatori
factor
product
express
immun
cell
monocytesmacrophag
cell
granulocyt
dc
well
colon
epitheli
cell
requir
express
subgroup
intestin
antimicrobi
peptid
cryptdin
interest
mice
suscept
pathogen
infect
via
oral
rout
intraven
periton
rout
report
indic
essenti
activ
adapt
immun
act
adjuv
receptor
ab
product
either
directli
enhanc
product
defensin
immunostimulatori
molecul
addit
report
function
chemoattract
variou
antigenpres
cell
apc
includ
immatur
dc
macrophag
chemokin
receptor
besid
recruit
apc
inflamm
site
modul
adapt
immun
respons
activ
signal
transduct
pattern
recognit
receptor
apc
matur
lead
product
cytokin
import
immunomodulatori
factor
also
modul
adapt
immun
respons
selfdestruct
signal
elimin
activ
apc
prevent
harm
effect
longactiv
dc
macrophag
therefor
may
counter
suppress
pathogenderiv
factor
gener
robust
host
primari
immun
respons
therebi
induc
effici
protect
immun
respons
collect
presum
hbd
abl
stimul
antivir
innat
immun
respons
also
specif
adapt
immun
respons
enhanc
deliveri
fuse
antigen
apc
vivo
consequ
assess
abil
hbd
promot
agspecif
immun
respons
induct
use
hbd
rbd
merscov
confirm
adjuv
abil
hbd
measur
induc
level
agspecif
igg
immun
rbd
alon
hbd
perform
receptorbind
viral
inhibit
assay
detect
quantifi
serumneutr
ab
merscov
use
viral
receptorexpress
host
cellbas
assay
expect
similar
result
agspecif
ab
within
respect
immun
sera
higher
virusneutr
activ
observ
sera
obtain
hbd
rbdimmun
mice
compar
mice
treat
rbd
alon
pb
fig
also
note
magnitud
inhibitori
effect
sera
hbd
agimmun
mice
gener
higher
similar
pattern
enhanc
induct
antivir
innat
immun
hbd
agtreat
cell
summari
conclud
hbd
activ
primari
antivir
innat
immun
respons
may
also
mediat
induct
effect
adapt
immun
respons
conjug
ag
result
indic
hbd
use
effect
antivir
vaccin
adjuv
provid
use
materi
research
antivir
innat
immun
respons
